National brain tumour research funding needs to increase to £30-35 million a year
Brain cancer patient says his chemo has been delayed by coronavirus pandemic
Ben Hurd is 33 and has been told he cannot continue with chemotherapy for an aggressive brain tumour because of the coronavirus pandemic.
The care home chef from South Yorkshire was diagnosed with a grade 4 glioblastoma multiforme last year and given the bleak prognosis that he could expect to live for 12 to 18 months.
He has already had surgery and radiotherapy and is part-way through chemotherapy which is his only chance of controlling the growth of the remaining tumour.
Ben has been working with Brain Tumour Research to share his story as an example of the additional pressures faced by cancer patients during lockdown.
Commenting on Ben’s story, our spokesman Hugh Adams said: “It is vital that brain tumour patients, who are being thrown into a world of uncertainty, work with their clinical teams and listen to any advice from them. To avoid that could be damaging to their well-being. Some tough decisions are being made and we know of clinical trials that are being halted which is terrible news for a research funding charity like us and it won’t lead to the new treatment options and better outcomes for patients which are desperately needed.”
If you found this story interesting or helpful, sign up to our weekly e-news and keep up to date with all the latest from Brain Tumour Research.